These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27042744)
1. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION. Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744 [TBL] [Abstract][Full Text] [Related]
2. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma. Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659 [TBL] [Abstract][Full Text] [Related]
3. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689 [TBL] [Abstract][Full Text] [Related]
4. Association of the Genetic Diversity of Killer Cell Immunoglobulin-like Receptor Genes and HLA-C Ligand in Saudi Women With Thyroid Cancer. Altalhi RA; Aljuaimlani A; Alswayyed M; Arafah M; Tashkandy Y; Almutairi BO; Mansour L; Alomar SY Cancer Control; 2024; 31():10732748241274495. PubMed ID: 39365900 [TBL] [Abstract][Full Text] [Related]
6. Association of killer cell immunoglobulin-like receptor and human leukocyte antigen-C genotype with dry eye disease in a Chinese Han population. Ren G; Shao T; Zhuang Y; Hu H; Zhang X; Huang J; Liu Y; Liu D Genet Test Mol Biomarkers; 2012 Aug; 16(8):910-4. PubMed ID: 22509813 [TBL] [Abstract][Full Text] [Related]
7. Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis. Sun HS; Liu DX; Bai YY; Hu NW Mod Rheumatol; 2019 May; 29(3):531-537. PubMed ID: 29848119 [TBL] [Abstract][Full Text] [Related]
8. Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer. Alomar SY; Alkhuriji A; Trayhyrn P; Alhetheel A; Al-Jurayyan A; Mansour L Immunogenetics; 2017 Feb; 69(2):69-76. PubMed ID: 27631728 [TBL] [Abstract][Full Text] [Related]
9. Killer cell immunoglobulin-like receptor along with HLA-C ligand genes are associated with type 1 diabetes in Chinese Han population. Zhi D; Sun C; Sedimbi SK; Luo F; Shen S; Sanjeevi CB Diabetes Metab Res Rev; 2011 Nov; 27(8):872-7. PubMed ID: 22069276 [TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-C and killer cell immunoglobulin-like receptor gene polymorphisms among patients with syphilis in a Chinese Han population. Zhuang YL; Ren GJ; Tian KL; Li XY; Zhu YB; Liu JL; Si GL; Li P; Zhang Y; Wang L; Zhang WJ; Wang DJ; Zhu CF APMIS; 2012 Oct; 120(10):828-35. PubMed ID: 22958291 [TBL] [Abstract][Full Text] [Related]
11. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage. Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478 [TBL] [Abstract][Full Text] [Related]
12. Distribution of killer cell immunoglobulin-like receptor genes and combinations with HLA-C ligands in an isolated Han population in southwest China. Shi L; Shi L; Tao Y; Lin K; Liu S; Yu L; Yang Z; Yi W; Huang X; Sun H; Chu J; Yao Y Tissue Antigens; 2011 Jul; 78(1):60-4. PubMed ID: 21542807 [TBL] [Abstract][Full Text] [Related]
13. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia. Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647 [TBL] [Abstract][Full Text] [Related]
14. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031 [TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation. Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065 [TBL] [Abstract][Full Text] [Related]
16. [Frequency of HLA-Cw and Its Corresponding Killer Cell Immunoglobulin-like Receptors (KIR) among Blood Donors in Chinese Nanjing Han Ethnic Group]. Lin H; Ma L; Xue M; Liu YC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1469-73. PubMed ID: 26524059 [TBL] [Abstract][Full Text] [Related]
17. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262 [TBL] [Abstract][Full Text] [Related]
18. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002 [TBL] [Abstract][Full Text] [Related]
19. HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients. Kim HJ; Choi HB; Jang JP; Baek IC; Choi EJ; Park M; Kim TG; Oh ST Int J Surg; 2014; 12(8):815-20. PubMed ID: 24998207 [TBL] [Abstract][Full Text] [Related]
20. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Varbanova VP; Mihailova S; Naumova E; Mihaylova AP Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]